ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶£¨Í¨Ñ¶Ô±ÕÅСȻ£©¼±ÐÔºôÎüÞ×¾Ý×ÛºÏÕ÷£¨ARDS£©ÊÇÒ»ÖÖÒÔ¼±ÐÔÃÖÂþÐÔÑ×Ö¢ÐÔ·ÎËðÉ˺ÍÑÏÖØµÍÑõÑªÖ¢ÎªÌØµãµÄºôÎüϵͳ¼±Î£ÖØÖ¢£¬£¬³£¼û²¡Òò°üÀ¨Å§¶¾Ö¢¡¢Ðݿˡ¢´´É˵ȡ£¡£¡£¡£ARDSµÄ·¢²¡ÂÊÔ¼60/10ÍòÈË£¬£¬éæÃüÂʽü50%¡£¡£¡£¡£ÏÖÔÚÕý¶Ô¸Ã²¡È±·¦ÓÐÓÃÖÎÁÆÒ©Î£¬ÈÔÒÔºôÎüÖ§³Ö¡¢ÓªÑøÖ§³ÖµÈÊÖ¶ÎΪÖ÷£¬£¬ÆÈÇÐÐèÒªÑз¢ÐµÄÖÎÁÆÕ½ÂÔ¡£¡£¡£¡£
¼ä³äÖʸÉϸ°û£¨MSC£©ÊÇÒ»ÖÖ×îÔç´Ó¹ÇËèÖÐÊèÉ¢£¬£¬Ëæºó·¢Ã÷ÆÕ±éÂþÑÜÓÚ»úÌå¸÷×éÖ¯µÄ³ÉÌå¸Éϸ°û¡£¡£¡£¡£ÒòÆäȪԴÆÕ±é¡¢Ò×ÓÚÀ©Ôö¡¢Äܹ»¶àÏò·Ö»¯£¬£¬¾ßÓÐÃâÒßµ÷ÀíºÍÐÞ¸´²¡Ëð×éÖ¯µÈ¹¦Ð§£¬£¬ÌáÐÑMSCÓÐÍû³ÉΪARDSÖÎÁƵĺòÑ¡·½°¸¡£¡£¡£¡£ÆðÔ´ÁÙ´²Ñо¿Ö¤ÊµMSCÖÎÁÆARDSÖеÄÇå¾²ÐÔ£¬£¬È»¶øÓÉÓÚ2ÆÚÁÙ´²ÊÔÑéÁÆÐ§²»Îȹ̣¬£¬ÖÆÔ¼ÁËMSCµÄÆÕ±éÓ¦Óᣡ£¡£¡£Òò´Ë£¬£¬ÏµÍ³ÆÊÎöMSCµÄÖÎÁÆ»úÖÆÖÁ¹ØÖ÷Òª¡£¡£¡£¡£
ÍŶÓǰÆÚ¿ªÕ¹µÄÒ»Ïîµ¥±ÛÁÙ´²Ñо¿ÖУ¬£¬22ÀýÖÐÖØ¶ÈARDS»¼ÕßÒÆÖ²µ¥¼ÁÁ¿MSCºó£¬£¬»¼ÕßÑõºÏÖ¸ÊýÔÚÊä×¢24СʱÄÚѸËÙ¸ÄÉÆ£¨Intensive Care Med. 2020£©¡£¡£¡£¡£Åãͬ×ÅÁÙ´²Ö¢×´µÄ¸ÄÉÆ£¬£¬ÎÒÃÇÊӲ쵽»¼Õß·ºÆðÐÄÂʼõÂý¡¢¶¯ÂöѹϽµµÄÇ÷ÊÆ£¬£¬ÌáÐѸ±½»¸ÐÉñ¾ÏµÍ³¿ÉÄܼÓÈëÁËMSCµÄÖÎÁÆÀú³Ì¡£¡£¡£¡£½øÒ»²½·¢Ã÷ÖÎÁÆÓÐÓõϼÕßÌåÄÚÒÒõ£µ¨¼îˮƽÏÔÖøÉÏÉý¡£¡£¡£¡£ÒÑÓÐÑо¿Ö¤Êµ£¬£¬¸±½»¸ÐÉñ¾²»µ«µ÷¿ØÐÄÂÊ¡¢ÑªÑ¹£¬£¬»¹¿ÉÒÔÊÍ·ÅÉñ¾µÝÖÊÒÒõ£µ¨¼î¿ØÖÆÈ«ÉíÑ×Ö¢·´Ó³£¬£¬±»³ÆÎªµ¨¼îÄÜ¿¹Ñ×ͨ·£¨CAP£©¡£¡£¡£¡£ÄÇô£¬£¬MSCÒÖÖÆ·ÎËðÉ˺óµÄÑ×Ö¢·´Ó³ÊÇ·ñÓ뵨¼îÄÜ¿¹Ñ×ͨ·Ïà¹ØÄØ£¿
ΪÁËÑéÖ¤ÕâÒ»¼ÙÉ裬£¬ngµç×ÓÓÎÏ·ÖÐɽҽѧԺÏîÅô½ÌÊÚ¡¢ngµç×ÓÓÎÏ·Á¥ÊôµÚÈýÒ½ÔºÒ×»ÛÃô½ÌÊÚ¿ÎÌâ×éÏàÖú¿ªÕ¹Ñо¿£¬£¬¿ËÈÕÔÚSignal Transduction and Targeted TherapyÉϽÒÏþÁËÌâΪ¡°Mesenchymal stromal cells alleviate acute respiratory distress syndrome through the cholinergic anti-inflammatory pathway¡±µÄÂÛÎÄ£¬£¬Ñо¿Õ¹ÏÖÁËMSCͨ¹ýµ÷¿Øµ¨¼îÄÜ¿¹Ñ×ͨ·ÒÖÖÆÑ×Ö¢£¬£¬ÖÎÁÆARDSµÄлúÖÆ¡£¡£¡£¡£
Ñо¿Ö°Ô±¹¹½¨Ð¡ÊóARDSÄ£×Ó£¬£¬·¢Ã÷¾²ÂöÊä×¢MSCÏÔ×Å»º½âÁË·ÎËðÉËÖ¢×´£¬£¬Í¬Ê±£¬£¬µ¨¼îÄÜϵͳÏà¹Ø»ùÒòChAT¡¢VAChTÔÚ·Î×éÖ¯Öбí´ïÁ¿ÏÔÖøÔöÌí£¬£¬ÌáÐÑCAP¿ÉÄÜÔÚMSCÖÎÁÆARDSµÄÀú³ÌÖÐʩչÖ÷Òª×÷Óᣡ£¡£¡£¿ÎÌâ×éËæºó֤ʵMSCÖ÷Ҫͨ¹ýºÏ³É¡¢ÉøÍ¸Ç°ÏßÏÙËØE2Ôö½øChAT±í´ïºÍÒÒõ£µ¨¼î±¬·¢¡£¡£¡£¡£
ΪÁ˽øÒ»²½Ì½Ë÷ÄÜ·ñͨ¹ýÖ±½Ó¼¤»îµ¨¼îÄÜ¿¹Ñ×ͨ·ÖÎÁÆARDS£¬£¬ÍŶӷ¢Ã÷½öÓÐÑ̼îÐÍÊÜÌ壨nAChR£©¼¤¶¯¼ÁÄܹ»ÏÔÖøÒÖÖÆÑ×Ö¢²¢¸ÄÉÆARDSÖ¢×´£¬£¬ÌáÐѵ÷¿Øµ¨¼îÄÜ¿¹Ñ×ͨ·¿ÉÄÜÊÇARDSÖÎÁƵÄÐÂ;¾¶¡£¡£¡£¡£ÔÚ´Ë»ù´¡ÉÏ£¬£¬Ñо¿Ö°Ô±ÊµÑéʹÓÃÑ̼îÐÍÒÒõ£µ¨¼îÊÜÌ弤¶¯Ò©ÎïÂå±´ÁÖ£¨Lobeline£©¶ÔARDS»¼Õß¾ÙÐÐÖÎÁÆ¡£¡£¡£¡£Óë½ö½ÓÊÜͨÀýÖÎÁƵϼÕßÏà±È£¬£¬½ÓÊÜLobelineÖÎÁƵÄ10Ãû»¼ÕßÔÚÖÎÁƺóÍ¨ÆøÖ¸ÊýÏÔןÄÉÆ£¬£¬²¢ÇÒ»¼Õß·ÎÅݹàÏ´ÒºIL-1¦Â¡¢TNF-¦ÁµÈÑ×Ö¢Òò×ÓÉøÍ¸ÏÔ×ÅïÔÌ£¬£¬ÓÐÓÃÌá¸ßÁËARDS»¼ÕßÉúÑÄÂÊ¡£¡£¡£¡£

ͼ£º£º£º MSCÖÎÁÆÍ¨¹ýCAP¸ÄÉÆ·ÎËðÉË
×ÛÉÏËùÊö£¬£¬ÍŶÓÖ°Ô±·¢Ã÷ÁËMSCÄܹ»Ôö½øÒÒõ£µ¨¼îµÄºÏ³ÉÓëÉøÍ¸£¬£¬Í¨¹ý¦Á7nAChRÒÀÀµµÄ;¾¶ÒÖÖÆ¾ÞÊÉϸ°ûÑ×Ö¢Òò×ӵı¬·¢£¬£¬ÓÐÓûº½â·Î²¿Ñ×Ö¢¡£¡£¡£¡£ÔÚ´Ë»ù´¡ÉÏ£¬£¬Ìá³öÁ˼¤»îµ¨¼îÄÜ¿¹Ñ×ͨ·ÖÎÁÆARDSµÄÐÂÕ½ÂÔ£¬£¬²¢Ì½Ë÷ÁË¡°ÀÏÒ©ÐÂÓá±ÖÎÁÆARDSµÄ¿ÉÄÜÐÔ£¬£¬¾ßÓÐÖ÷ÒªµÄÁÙ´²ÒâÒå¡£¡£¡£¡£
ngµç×ÓÓÎÏ·ÖÐɽҽѧԺÏîÅô½ÌÊÚºÍngµç×ÓÓÎÏ·Á¥ÊôµÚÈýÒ½ÔºÒ×»ÛÃô½ÌÊÚΪ±¾ÂÛÎĵÄͨѶ×÷Õߣ¬£¬ÕÅÐ¡È»ÌØÆ¸¸±Ñо¿Ô±Îª¸ÃÂÛÎĵÄ×ÔÁ¦µÚÒ»×÷Õß¡£¡£¡£¡£ÏîÅô½ÌÊÚºã¾Ã´ÓʸÉϸ°û¶àÄÜÐÔÓë×éÖ¯Æ÷¹ÙÔÙÉúÑо¿£¬£¬ÔÚ¸Éϸ°ûÖÎÁƵĻù´¡Ñо¿ÓëÁÙ´²×ª»¯·½ÃæÈ¡µÃÍ»³öЧ¹û¡£¡£¡£¡£
ÂÛÎÄÁ´½Ó£º£º£ºhttps://www.nature.com/articles/s41392-022-01124-6